Nutrien Ltd. completed the sale of its 50 % equity position in Argentina‑based nitrogen producer Profertil S.A. on December 10, 2025, receiving $600 million in proceeds on a pre‑tax basis. The transaction was executed with Adecoagro S.A. and the Asociación de Cooperativas Argentinas (ACA), the same buyers that acquired the remaining 50 % stake in 2023.
The divestiture removes a non‑core asset that had contributed roughly $60 million in earnings to Nutrien’s nitrogen segment over the past four quarters and an average annual EBITDA of about $390 million between 2020 and 2024. By shedding Profertil, Nutrien reduces earnings volatility tied to Argentina’s economic environment and frees capital that can be deployed toward higher‑return opportunities, share repurchases, and debt reduction.
Ken Seitz, Nutrien’s President and CEO, said the sale “demonstrates continued progress toward simplifying our portfolio, enhancing earnings quality, and improving cash conversion.” He added that the proceeds will be used to support long‑term free‑cash‑flow growth, underscoring the company’s commitment to capital allocation discipline.
The sale is part of a broader portfolio of divestitures that have generated approximately $900 million in gross proceeds since late 2024. Nutrien’s strategy is to focus on its core potash, nitrogen, and retail businesses, while reducing exposure to high‑risk, low‑margin operations.
Industry analysts note that Nutrien’s move aligns with a broader trend of fertilizer companies streamlining operations in response to market volatility caused by geopolitical events and commodity price swings. The company’s strong free‑cash‑flow yield and low debt‑to‑equity ratio position it well to capitalize on opportunities in its core markets.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.